Furthermore, there were significant differences with regards to the prognostic significance of the above molecular markers, with TP53, KRAS and MTOR alterations predicting a worse prognosis in ICC, and BAP1, PBRM1 and chromatin modulating genes linked to a worse survival in ECC. This evidence concerns the gene TP53 and intrahepatic cholangiocarcinoma.